In premenopausal women, obesity is associated with a lower risk of estrogens receptor positive (ER+) breast cancer and a higher risk of triple‐negative breast cancers (ER, progesterone receptor, PR, and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.